Literature DB >> 19809863

Elevated serum homocysteine level is not associated with serum C-reactive protein in patients with probable Alzheimer's disease.

Orhan Lepara1, Azra Alajbegovic, Asija Zaciragic, Emina Nakas-Icindic, Amina Valjevac, Dzenana Lepara, Almira Hadzovic-Dzuvo, Almir Fajkic, Aida Kulo, Emin Sofic.   

Abstract

Elevated plasma homocysteine (Hcy) levels have been associated with Alzheimer's disease (AD) and cognitive impairment. Studies have shown that Hcy may have direct and indirect neurotoxicity effects. The aim of the study was to investigate serum Hcy concentration in patients with probable AD with age-matched controls and to determine whether there was an association between serum Hcy and C-reactive protein concentration in patients with probable AD. We also aimed to determine whether there was an association between serum tHcy concentration and cognitive impairment in patients with probable AD. Serum concentration of total Hcy was determined by the fluorescence polarization immunoassay on the AxSYM system, and serum C-reactive protein (CRP) concentration was determined by means of particle-enhanced immunonephelometry with the use of BN II analyzer. Cognitive impairment was tested by the MMSE score. Body mass index (BMI) was calculated for each subject included in the study. Age, systolic and diastolic blood pressure and BMI did not differ significantly between the two groups. Mean serum tHcy concentration in the control group of subjects was 12.60 mumol/L, while in patients with probable AD the mean serum tHcy concentration was significantly higher than 16.15 mumol/L (p < 0.01). A significant negative association between serum tHcy concentration and cognitive impairment tested by the MMSE score in patients with probable AD was determined (r = -0.61634; p < 0.001). Positive, although not significant correlation between CRP and serum tHcy concentrations in patients with AD, was observed. Increased tHcy concentration in patients with probable AD, and the established negative correlation between serum tHcy concentration and cognitive damage tested by MMSE score in the same group of patients, suggests the possible independent role of Hcy in the pathogenesis of AD and cognitive impairment associated with this disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19809863     DOI: 10.1007/s00702-009-0325-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  30 in total

1.  Homocysteine and folate as risk factors for dementia and Alzheimer disease.

Authors:  Giovanni Ravaglia; Paola Forti; Fabiola Maioli; Mabel Martelli; Lucia Servadei; Nicoletta Brunetti; Elisa Porcellini; Federico Licastro
Journal:  Am J Clin Nutr       Date:  2005-09       Impact factor: 7.045

Review 2.  Biomarkers of Alzheimer disease in plasma.

Authors:  Michael C Irizarry
Journal:  NeuroRx       Date:  2004-04

3.  Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease.

Authors:  R Poddar; N Sivasubramanian; P M DiBello; K Robinson; D W Jacobsen
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

4.  Hyperhomocysteinemia in dementia.

Authors:  F Leblhuber; J Walli; E Artner-Dworzak; K Vrecko; B Widner; G Reibnegger; D Fuchs
Journal:  J Neural Transm (Vienna)       Date:  2000       Impact factor: 3.575

5.  Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study.

Authors:  N D Prins; T Den Heijer; A Hofman; P J Koudstaal; J Jolles; R Clarke; M M B Breteler
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

6.  Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

Authors:  F Licastro; S Pedrini; L Caputo; G Annoni; L J Davis; C Ferri; V Casadei; L M Grimaldi
Journal:  J Neuroimmunol       Date:  2000-02-01       Impact factor: 3.478

Review 7.  [The neurologist role in diagnostics and therapy of the Alzheimer's disease].

Authors:  Nedim Loncarević; Enra Mehmedika-Sulić; Azra Alajbegović; Abdulah Kucukalić
Journal:  Med Arh       Date:  2005

8.  Homocysteine and cognitive function in healthy elderly community dwellers in Italy.

Authors:  Giovanni Ravaglia; Paola Forti; Fabiola Maioli; Antonio Muscari; Loredana Sacchetti; Giorgia Arnone; Valeria Nativio; Teresa Talerico; Erminia Mariani
Journal:  Am J Clin Nutr       Date:  2003-03       Impact factor: 7.045

9.  Inflammatory markers and cognition in well-functioning African-American and white elders.

Authors:  K Yaffe; K Lindquist; B W Penninx; E M Simonsick; M Pahor; S Kritchevsky; L Launer; L Kuller; S Rubin; T Harris
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

10.  Total serum homocysteine in senile dementia of Alzheimer type.

Authors:  A McCaddon; G Davies; P Hudson; S Tandy; H Cattell
Journal:  Int J Geriatr Psychiatry       Date:  1998-04       Impact factor: 3.485

View more
  2 in total

Review 1.  Blood-based biomarkers of Alzheimer's disease: challenging but feasible.

Authors:  Madhav Thambisetty; Simon Lovestone
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

Review 2.  IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer's disease: Systematic Review and Meta-Analysis.

Authors:  Ada Ng; Wilson W Tam; Melvyn W Zhang; Cyrus S Ho; Syeda F Husain; Roger S McIntyre; Roger C Ho
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.